Moving toward consensus on diagnosis and management of severe asthma in adults

Daniel Colodenco, Oscar Palomares, Carlos Celis, Alan Kaplan, Christian Domingo

    Research output: Contribution to journalReview articleResearchpeer-review

    5 Citations (Scopus)

    Abstract

    © 2017 Informa UK Limited, trading as Taylor & Francis Group. Asthma is a considerable health problem with an increasing global prevalence. The burden of severe asthma is expected to notably increase in the following years. Some misleading concepts that sometimes appear in the literature can drive the physician responsible for a patient’s management to make incorrect decisions. Furthermore, some of the concepts that appear in the literature and in the guidelines may not be clear to understand, follow or adapt to regional and local realities. This could again drive the physicians responsible for a patient’s management to make incorrect clinical judgments. In this article, we review the definition, prevalence and immunopathology of severe asthma, describe the asthma phenotypes, clinical features and comorbidities, the diagnosis of severe asthma and personalized asthma treatment. At the end, we offer a treatment approach based on literature publications, personalized medicine and marketed biologic treatment options.
    Original languageEnglish
    Article numberST-0289.R1/1380617
    Pages (from-to)387-399
    JournalCurrent Medical Research and Opinion
    Volume34
    Issue number3
    DOIs
    Publication statusPublished - 1 Jan 2017

    Keywords

    • Consensus
    • Diagnosis
    • Disease management
    • Severe asthma
    • Treatment

    Fingerprint

    Dive into the research topics of 'Moving toward consensus on diagnosis and management of severe asthma in adults'. Together they form a unique fingerprint.

    Cite this